Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7397)
All Articles published online
|
Publishing Process of This Article
|
Jul 6, 2019 (publication date) through Dec 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang MY, Niu JQ, Wen XY, Jin QL. Liver failure associated with benzbromarone: A case report and review of the literature. World J Clin Cases 2019; 7(13): 1717-1725 [PMID: 31367632 DOI: 10.12998/wjcc.v7.i13.1717] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v7/i13/1717.htm |
| Number | Citing Articles |
| 1 |
Yun-Hong Cheon, Jung Soo Song. What is the Best Choice for Urate-lowering Therapy for Korean?. Journal of Rheumatic Diseases 2020; 27(2): 78 doi: 10.4078/jrd.2020.27.2.78
|
| 2 |
A. A. Garanin, N. L. Novichkova, N. L. Novichkova. Prospects of anti-inflammatory and urate-lowering therapy of gout: A vector from the past to the future. Rheumatology Science and Practice 2022; 60(2): 205 doi: 10.47360/1995-4484-2022-205-213
|
| 3 |
Wenwen Zhang, Yifang Cui, Zihan Liu, Shaoping Wang, Ailin Yang, Xiulian Li, Jiayu Zhang. Astragalus membranaceus ultrafine powder alleviates hyperuricemia by regulating the gut microbiome and reversing bile acid and adrenal hormone biosynthesis dysregulation. Arabian Journal of Chemistry 2022; 15(9): 103970 doi: 10.1016/j.arabjc.2022.103970
|
| 4 |
Alessandro Maloberti, Valentina Colombo, Francesca Daus, Lorenzo De Censi, Maurizio Giuseppe Abrignani, Pier Luigi Temporelli, Giulio Binaghi, Furio Colivicchi, Massimo Grimaldi, Domenico Gabrielli, Claudio Borghi, Fabrizio Oliva. Two still unanswered questions about uric acid and cardiovascular prevention: Is a specific uric acid cut-off needed? Is hypouricemic treatment able to reduce cardiovascular risk?. Nutrition, Metabolism and Cardiovascular Diseases 2024; : 103792 doi: 10.1016/j.numecd.2024.103792
|
| 5 |
Xiaowei Luo, Lipeng Zhou, Shukai Wang, Jing Yuan, Zihao Chang, Qian Hu, Yinxin Chen, Yuqi Liu, Ya Huang, Baojin Wang, Ye Gao, Zhaohui Wang, Yitong Cui, Yue Liu, Lanzhen Zhang. The Therapeutic Effect and the Potential Mechanism of Flavonoids and Phenolics of Moringa oleifera Lam. Leaves against Hyperuricemia Mice. Molecules 2022; 27(23): 8237 doi: 10.3390/molecules27238237
|
| 6 |
Connor J. Hughes, Christopher Alderman, Arthur R. Wolin, Kaiah M. Fields, Rui Zhao, Heide L. Ford. All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(3): 189098 doi: 10.1016/j.bbcan.2024.189098
|
| 7 |
Tomotaka Ishii, Keijiro Hoshino, Masayuki Honda, Yoichiro Yamana, Reina Sasaki-Tanaka, Mariko Kumagawa, Shini Kanezawa, Taku Mizutani, Naoki Matsumoto, Ryota Masuzaki, Kazushige Nirei, Hiroaki Yamagami, Mitsuhiko Moriyama, Tatsuo Kanda. A Case of Recent Liver Injury Induced by Benzbromarone. Reports 2022; 5(1): 8 doi: 10.3390/reports5010008
|
| 8 |
Zihan Hou, Aijinxiu Ma, Jiale Mao, Danni Song, Xu Zhao. Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout. Expert Opinion on Drug Metabolism & Toxicology 2023; 19(12): 895 doi: 10.1080/17425255.2023.2287477
|
| 9 |
N. A. Konyshko, T. E. Morozova, V. V. Tsurko, G. S. Konyshko. Hyperuricemia, gout and digestive system pathology: common links of pathogenesis. Experimental and Clinical Gastroenterology 2024; (11): 130 doi: 10.31146/1682-8658-ecg-219-11-130-137
|
| 10 |
Mizuki Yamane, Fumihiko Igarashi, Tsuyoshi Yamauchi, Toshito Nakagawa. Main contribution of UGT1A1 and CYP2C9 in the metabolism of UR-1102, a novel agent for the treatment of gout. Xenobiotica 2021; 51(1): 61 doi: 10.1080/00498254.2020.1812012
|
| 11 |
Yuan Hong, Xichuang Chen, Zhiping Li, Xiaoyan Zhang, Cong Zhou, Yan Wang, Guangfei Wang, Wei Wu, Danli Zhou, Hai feng Li. A lifetime economic research of universal HLA-B*58:01 genotyping or febuxostat initiation therapy in Chinese gout patients with mild to moderate chronic kidney disease. Pharmacogenetics and Genomics 2023; 33(2): 24 doi: 10.1097/FPC.0000000000000488
|
| 12 |
M.V. Tkachenko, M.Yu. Babanina, H.V. Volchenko, Ye.M. Kitura, O.A. Kyryan . MODERN VIEW ON ANTI-INFLAMMATORY AND URAT-LOWERING THERAPY FOR GOUT. Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії 2023; 23(3): 217 doi: 10.31718/2077-1096.23.3.217
|